Project Details
Description
The aim of this one-year project is to generate policy-relevant evidence on gaps in the use of pharmacotherapy
for lowering CVD risk in people at high risk, particularly those with type 2 diabetes.
Status | Finished |
---|---|
Effective start/end date | 1/09/17 → 1/09/18 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.